Intellia Therapeutics, Inc. (NTLA) Revenue History
Intellia Therapeutics, Inc. (NTLA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $16.48M |
| 2017-12-31 | $26.12M |
| 2018-12-31 | $30.43M |
| 2019-12-31 | $43.10M |
| 2020-12-31 | $57.99M |
| 2021-12-31 | $33.05M |
| 2022-12-31 | $52.12M |
| 2023-12-31 | $36.27M |
| 2024-12-31 | $57.88M |
| 2025-12-31 | $67.67M |
How NTLA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc. | $65.32M |
| NKTR | Nektar Therapeutics | $55.23M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
These are five companies in the same sector as NTLA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Intellia Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("NTLA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NTLA | $12.26 | +1.16% | 4.50M |
| 3 | ||||
| 4 | ||||
| 5 |